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Abstract
Objective—Hematopoietic stem cell transplantation (HSCT) is a demanding cancer treatment
associated with enduring physical and psychological complications. Survivors' well-being may be
further compromised by exposure to chronic stressors common to this population, including
difficulties arising from costly medical care, changes in employment status, and health insurance
coverage. Thus, we hypothesized that financial, employment, and insurance stressors (collectively
referred to as economic survivorship stressors) would be associated with poorer health-related
quality of life (HRQOL) among HSCT survivors.
Methods—Survivors (n=181; M=640 days post-transplant) completed measures of study
variables through mailed questionnaires and telephone interviews. Hierarchical regression
analyses were conducted to test the hypothesized associations between economic survivorship
stressors and HRQOL, and to examine whether social and situational factors interact with
survivors' stress perceptions to predict HRQOL.
Results—Greater financial and employment stress were associated with poorer functioning
across multiple HRQOL domains, even after controlling for the effects of possible confounding
sociodemographic and medical variables. Insurance stress was not associated with HRQOL. Some
associations were moderated by situational factors including timing of the current financial crisis
and portion of the transplant paid for by health insurance.
Conclusions—HSCT survivors can face serious economic challenges during recovery. Results
suggest the value of viewing these challenges as chronic stressors capable of reducing survivors'
mental and physical well-being. Identifying resources and skills that help survivors cope with
these demands is an important goal for clinicians and researchers.
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Hematopoietic stem cell transplantation (HSCT) is a demanding treatment for hematologic
malignancies. The toxic preparative regimen most patients receive (high-dose
chemotherapy, sometimes with total body irradiation) suppresses or destroys their immune
function, necessitating protective isolation and causing side effects including fatigue,
cognitive difficulties, and sexual dysfunction [1–2]. For many survivors these difficulties are
resolved within the first year after transplant; however, they can persist, and survivors
continue to face increased risk of all-cause mortality [3–5]. HSCT has also been associated
with depression, anxiety, fear of cancer recurrence, and symptoms of post-traumatic stress
disorder before, during, and after transplant [4, 6–7].
These physical and psychological effects occur in conjunction with practical difficulties that
have been conceptualized as chronic stressors in other populations. Here we focus on three
that are interrelated and commonly reported after transplant: persistent financial,
employment, and insurance stressors. These stressors (which we refer to collectively as
economic survivorship stressors) have the potential to exacerbate negative physical and
psychological effects of transplant, thereby reducing survivors' health-related quality of life
(HRQOL). HRQOL encompasses the extent to which survivors experience a sense of well-
being, have the ability to carry out activities of daily living, and experience disease-related
symptoms. It represents a critical aspect of the transplant recovery and survivorship
experience, and economic survivorship stressors may adversely affect HRQOL through
biological, behavioral, and psychological pathways [8–9]. For instance, financial stress
(perceived inadequacy of financial resources) is associated with worse physical and
psychological health in community populations [10–12], and has been associated with
decreased HRQOL and elevated distress among low-income survivors of breast and
gynecologic cancers [13]. Cancer-related financial stress and strain have also been
associated with adverse psychological well-being among survivors of breast, prostate, and
lung cancer [14]. Furthermore, qualitative work conducted with cancer survivors and their
caregivers has demonstrated that financial worries and difficulties have a negative impact on
family lifestyle, activities, roles, and relationships [15]. In HSCT, the potential for financial
stress is high because of the costliness of the treatment [2], and additional expenses due to
treatment-related complications, medications, transportation to and from transplant facilities,
and routine medical follow-up.
Employment-related problems are associated with financial stress, in addition to being
stressful in their own right. Cancer survivors report difficulties including non-supportive
work environments, changes in work schedules and relationships with colleagues, perceived
employer discrimination, and reductions in perceived work ability, all of which may be
persistent areas of concern with implications for their return to work, financial standing, and
overall well-being [16]. Among HSCT survivors, enduring physical effects of transplant can
prevent or substantially delay return to work [6]. One study found that approximately 40%
of HSCT survivors had not returned to work 1-year post-transplant, and approximately 30%
had not returned 2-years post-transplant [17]. Caregivers also lose income due to missed
work, and incur substantial out-of-pocket expenses in order to stay at or near the treatment
center [18].
Finally, many transplant survivors struggle with health insurance claims, policy caps, and
obtaining future coverage. In one study approximately 32% of survivors reported that
obtaining insurance was problematic, and 31% reported concerns about changing jobs for
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fear of losing health insurance coverage [19]. In a study of 10-year survivors of HSCT, 24%
reported a history of health insurance denial compared to 0% of age-, sex-, and race-
matched controls [5]. In addition to being a source of stress and frustration, insurance
problems may increase financial burden among survivors who require ongoing surveillance.
The role of insurance stress in cancer survivors' HRQOL has not been explored, although
health insurance status has been shown to predict HRQOL in some studies. For instance,
lack of insurance coverage has been associated with poorer HRQOL among survivors of
prostate cancer [20]. However, insurance status was unrelated to HRQOL in a sample of
Hispanic and African-American cancer patients [21].
The present study investigated these economic survivorship stressors and their association
with HRQOL among survivors of HSCT. Participants were 181 men and women who had
undergone HSCT 9–36 months prior to assessment. First, we examined survivors' post-
transplant perceptions of financial, employment, and insurance stressors. Second, we
investigated these perceived stressors as predictors of survivors' HRQOL, hypothesizing that
greater economic survivorship stress would be associated with poorer HRQOL. Because
stress and coping theory posits that people's perceptions of a situation (as opposed to the
situation's objective characteristics) are most important in determining health [22], we
predicted that associations between economic survivorship stress and HRQOL would remain
even after controlling for objective indicators of socioeconomic position including income,
education, and employment status. We also examined potential confounding effects of
survivors' sociodemographic and medical characteristics on the hypothesized associations.
A final, exploratory aspect of this study was based on the fact that people's social
environments and personal resources influence how they appraise and respond to a stressor
[22]. Informed by both relative deprivation theory [23–24], which predicts that greater
financial disparities are associated with poorer health in part because people experience
distress when they perceive their economic standing as worse than others, and social
comparison theory [25], which posits that people compare themselves to others when
evaluating themselves on a particular dimension, we reasoned that survivors would appraise
economic survivorship stressors differently depending on their economic standing relative to
others in their social environment. We investigated the effects of the financial crisis that
occurred during this study, which led to a sudden, profound shift in the economic well-being
of many Americans. We hypothesized that, compared to survivors who completed the study
before the crisis, those who completed it after the crisis would appraise each of these
stressors as less dire because of the knowledge that many people were experiencing similar
problems. Although pinpointing the exact timing of the recession is difficult, experts
identify the very public failures in the financial sector in September 2008 as a pivotal
turning point [26–27]. We also examined whether the portion of survivors' transplant paid
by health insurance, which varies across individuals and affects how much of the treatment
costs they bear, would moderate the association between economic survivorship stress and
HRQOL. This situational factor may influence how people appraise their financial demands;
thus, we predicted that the adverse effects of each economic survivorship stressor on
HRQOL would be amplified among those participants whose insurance covered the smallest
portions of their transplant expenses.
Methods
Participants were recruited through advertisements and physician referrals from Mount Sinai
Medical Center and Hackensack University Medical Center as part of an IRB-approved
larger study examining the efficacy of a psychosocial intervention for distressed HSCT
survivors. Data for this report were obtained prior to any intervention. Eligible individuals
underwent HSCT 9–36 months prior to assessment, were at least age 18 (and older than 16
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at the time of HSCT), English-speaking with telephone access, not currently relapsed, and at
least moderately distressed according to a screening interview that used standardized
measures of generalized and cancer-specific distress.1
Interested individuals (n=272) completed screening telephone interviews to determine their
eligibility after completing informed consent procedures. Eligible participants (n=238) were
mailed a questionnaire including measures of perceived financial, employment, and
insurance stressors, which was to be completed prior to a scheduled telephone interview.
During the interview, participants provided sociodemographic, medical, and psychosocial
information, including HRQOL. At the time of this report, 199 participants had completed
the questionnaire and interview.
Measures
Financial stressors were assessed with two highly correlated (r=.72, p<.001) measures. The
first (3 items rated from 1=“not at all” to 5=“a great deal”;[33–34]) assessed how difficult it
is for people to live on their income currently, and the extent to which they anticipate facing
actual financial hardships or needing to reduce their standard of living over the next two
months (in the present study, Cronbach's α=.80). The second measure (6 items rated from
1=“not at all” to 4=“a great deal”;[35–36]) assessed how often in the past month people
engaged in behaviors such as borrowing money to pay bills or putting off non-emergency
medical treatment because of cost (in the present study, α=.86). A composite financial stress
score was computed by summing standardized scores that were linearly transformed to
remove negative values. Scores ranged from 0–8.1; higher scores indicate greater perceived
financial stress.
Employment stressors were assessed with 12 items developed for this study to measure
employment problems likely to be encountered by HSCT survivors. Because no existing
measures capture perceptions of employment problems specific to this population, item
development was informed by a review of the literature regarding social and practical
concerns among HSCT survivors [6], and was guided by the content of feedback the
research team received from HSCT survivors participating in a prior study. Items were
modeled on classic, well-validated measures of life stressors [e.g., 33, 37]. Items assessed
problems including needing to return to work too soon or having an unsupportive employer
(see Appendix A for complete measure). If participants were working at the time of
diagnosis or transplant (assessed by a separate item), they indicated whether they had
experienced each problem since their diagnosis or transplant (0=no, 1=yes) and the extent to
which it was upsetting (0=“not at all” to 4=“extremely”). Responses to these two questions
were multiplied for each item and the resulting products were summed. Scores ranged from
0–48; higher scores indicate greater perceived employment stress (α=.76). Scores of 0 were
imputed for participants not employed at the time of diagnosis or transplant.
Insurance stressors were assessed with 8 items developed for this study to measure
insurance-related problems likely to be encountered by HSCT survivors. No existing
measures assess perceptions of insurance-related problems specific to this population, yet
feedback received by the research team from participants in a prior study identified
insurance stressors as an unaddressed problem among HSCT survivors. Therefore, as above,
item development was informed by literature on practical problems of HSCT survivorship,
comments of prior study participants, and classic measures of life stressors. Items assessed
problems including losing health insurance or an insurance company denying payment (see
1Eligible participants demonstrated at least moderate distress on one or more of the following measures: Impact of Event Scale [28],
Brief Symptom Inventory-Global Severity Index [29], Functional Assessment of Cancer Therapy-Bone Marrow Transplant scale [30–
31], or Life Engagement Test [32]. Exact cut-offs are available from the last author.
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Appendix B for complete measure). For each item, participants indicated whether they had
experienced the problem during the course of their illness or transplant (0=no, 1=yes) and
the extent to which it was upsetting (0=“not at all” to 4=“extremely”). These responses were
multiplied for each item and the resulting products were summed. Scores ranged from 0–32;
higher scores indicate greater perceived insurance stress (α=.69).
Health-related quality of life was assessed with the well-validated Functional Assessment of
Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale, Version 4 [30–31]. This
measure includes five reliable subscales: physical well-being (α=.85), social/family well-
being (α=.76), emotional well-being (α=.75), functional well-being (α=.81), and transplant-
specific concerns (α=.65). Higher scores indicate better HRQOL.
Sociodemographic characteristics included age, ethnicity, gender (0=male, 1=female),
current employment status (0=unemployed, 1=employed by self or others), years of
education, and annual household income (ranging from less than $20,000 to over $110,000).
Medical variables included self-reported HSCT transplant type (0=autologous,
1=allogeneic) and the month and year transplant occurred. Medical comorbidities were
assessed with the Self-Administered Comorbidity Questionnaire [38], a self-report measure
which correlates with a medical record-based comorbidity instrument, patient health status,
and healthcare utilization. Scores range from 0–42; higher scores indicate greater
comorbidities.
Timing of the financial crisis was indicated by coding mailed questionnaires completed prior
to September 1, 2008 as 0, and those completed on or after September 1, 2008 as 1.
Insurance information included whether participants had health insurance that paid for their
transplant (0=no, 1=yes), and the portion of their transplant it paid (ranging from 1=“none”
to 4=“all”). For descriptive purposes only, information about participants' type of insurance
was also collected.
Statistical Analysis
Data were screened for missing values and violations of necessary analytic assumptions, and
descriptive statistics and bivariate correlations were computed. Hierarchical linear
regression was used to test whether each type of economic survivorship stress was
associated with HRQOL after controlling for potential confounding variables. Thus, models
were tested in which each HRQOL subscale (physical, social/family, emotional, functional,
and transplant-specific concerns) was regressed separately on sociodemographic
characteristics (age, ethnicity, gender, employment status, education, and income; step 1),
medical variables (comorbidities, transplant type, and days since transplant; step 2), and
economic survivorship stress (financial, employment, and insurance stress; step 3). Because
we hypothesized that financial, employment, and insurance stress would be associated with
HRQOL independently of indicators of socioeconomic position, all models included
employment status, education, and income. Furthermore, because employment and
insurance patterns differ by age [39], age was included as a covariate in all models; any
other sociodemographic or medical variables were included based on a significant
correlation (p≤.05) with the HRQOL outcome for a given model.
We examined the role of potential moderators (timing of the financial crisis and portion of
the transplant paid by insurance) in an exploratory manner. For example, to test the
interaction between financial stress and timing of the financial crisis, we included significant
covariates and other significant types of economic survivorship stress in the initial steps of
the model, and then added financial stress and timing of the crisis (i.e., the main effects),
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followed by an interaction term for financial stress and timing of the crisis. These analyses
used mean-centered continuous variables to reduce multicollinearity [40]. Significant
interactions were plotted by solving the regression equation including all predictors and
covariates [40]. All statistical tests were 2-tailed with α=.05.
Results
After the removal of 18 participants with substantial missing data, data were available for
181 HSCT survivors who completed the questionnaire prior to (M=9.1, SD=10.9 days) the
interview. Participant characteristics appear in Table 1; bivariate correlations and descriptive
data appear in Table 2.
Perceptions of Economic Survivorship Stressors
On average, participants reported relatively low financial stress (M=1.81, SD=1.85).
However, participants' scores spanned the scale's range, demonstrating the variability of
their responses. Sources of financial stress most frequently endorsed as occurring
moderately or a great deal in the past month included reducing or cancelling vacations or
leisure activities (34% of participants), reducing spending on household expenses such as
food or clothing (33%), and deciding not to buy something they had planned to purchase
(28%). Additionally, 23% of participants felt it was difficult, very difficult, or extremely
difficult to live on their income, and 22% at least somewhat anticipated needing to reduce
their standard of living to the bare necessities of life.
Although 73% of participants were working at the time of their diagnosis or transplant, only
44% were currently employed. On average, participants reported relatively low employment
stress since the time of their diagnosis or transplant (M=8.15, SD=6.88 among those
employed at the time of diagnosis or transplant; M=6.28, SD=6.87 among the full sample);
however, 87% of those employed at the time of diagnosis or transplant reported some
employment stress. Among these participants, the most common problem was a pay cut or
loss of income due to their illness (reported by 67% of participants, of whom 46% reported
it was very or extremely upsetting). The next most common problems included needing to
go on disability (63% of participants) and needing to take a paid leave of absence (55%).
These problems were reported as very or extremely upsetting by 29% and 18% of those who
experienced these stressors, respectively.
All but one participant (n=180) had health insurance at the time of transplant. Most (59%)
reported that insurance paid for all their transplant expenses. On average, insurance stress
experienced during the course of their illness or transplant was low (M=3.43, SD=4.68);
41% of participants reported no insurance stress. Among participants who did experience
problems, the most common involved spending a lot of time dealing with their health
insurance company (reported by 38% of participants, of whom 51% reported it was very or
extremely upsetting), someone else spending a lot of time dealing with their insurance
company (34% of participants, of whom 33% reported it was very or extremely upsetting),
and the insurance company denying a payment (22% of participants, of whom 76% reported
it was very or extremely upsetting).
Economic Survivorship Stress and HRQOL
Results of the hierarchical regression analyses indicated that financial stress was most
consistently related to HRQOL (Table 3). As predicted, it was inversely associated with
physical well-being (p<.001), emotional well-being (p=.001), functional well-being (p=.
005), and transplant-related concerns (p=.001). Similarly, employment stress was inversely
related to physical well-being (p<.001), functional well-being (p=.01), and transplant-
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specific concerns (p<.001). Insurance stress did not predict HRQOL. One aspect of HRQOL
—social/family well-being—was unrelated to economic survivorship stress.
Moderation Analyses
Additional analyses suggested that timing of the financial crisis and portion of transplant
paid by insurance did moderate some associations between types of economic survivorship
stress and HRQOL; however, when the analyses were corrected for multiple comparisons,
these effects exceeded the conservative Bonferroni-corrected α=.01 and thus should be
interpreted as marginally significant. Specifically, results suggested that the timing of the
financial crisis moderated the association between financial stress and emotional well-being,
t(175)=2.41, p=.02, effect size (partial r)=.18. As shown in Figure 1, the inverse association
between financial stress and emotional well-being was stronger for participants assessed
before the financial crisis than for participants assessed after the crisis. Timing of the
financial crisis also moderated the association between employment stress and physical
well-being, t(173)=2.40, p=.02, effect size=.18; and between employment stress and
functional well-being, t(173)=2.03, p=.04, effect size=.15. These interactions demonstrated a
pattern similar to that shown in Figure 1. Thus, the inverse association between employment
stress and HRQOL was stronger for participants assessed before the crisis than for
participants assessed after.
We confirmed that survivors assessed before and after the crisis differed in neither their
mean financial (t(179)= −1.15, p=.25) nor employment (t(179)= −1.27, p=.21) stress,
thereby highlighting the influence of survivors' psychological rather than objective burden
on HRQOL.2 To further explore these interactions, we used the regression equations to
predict survivors' HRQOL at the highest levels of stress reported in our sample, and
compared these predicted values to published norms for transplant recipients' HRQOL 1-
year post-transplant [41].3 At the highest level of financial stress, emotional well-being
among survivors assessed after the crisis (predicted M=14.1) was similar to the published
norm for this HRQOL subscale (M=16.8, SD=2.5;[41]); however, emotional well-being
among survivors assessed before the crisis (predicted M=7.8) was far worse (i.e., more than
three SDs below the published norm). Similar patterns emerged upon comparing the
published norm for physical well-being (M=22.6, SD=4.8;[41]) to survivors' physical
HRQOL at the highest level of employment stress for those assessed after (predicted
M=19.9) as opposed to before (predicted M=14.9) the crisis, and upon comparing the
published norm for functional well-being (M=19.5, SD=5.0;[41]) to survivors' functional
HRQOL for those assessed after (predicted M=19.6) as opposed to before (predicted
M=15.9) the crisis.
Additionally, results suggested that the portion of the transplant paid by health insurance
moderated the association between financial stress and transplant-specific concerns,
t(167)=2.25, p=.03, effect size=.17. As shown in Figure 2, this inverse association of
financial stress with HRQOL was stronger for participants whose insurance paid less than all
of their expenses than for those whose insurance paid all of their expenses. Portion of the
transplant paid by insurance did not moderate any other associations between stress and
HRQOL. Mean financial stress did not differ among survivors based on portion of transplant
paid by insurance, t(171)=.22, p=.83. Additional comparisons indicated that at the highest
level of financial stress, the transplant-specific HRQOL of survivors whose insurance paid
2These two groups also did not differ on any sociodemographic, medical, or other study variables (all ps≥.08), suggesting that group
differences were not due to methodological factors (e.g., bias due to joining the trial earlier compared to later).
3Published norms only exist for the FACT-BMT Version 3. To allow comparisons across Versions 3 and 4, adjustments were made to
participants' scores on the emotional subscale [30]. No adjustments were required for the physical and functional subscales due to item
similarly across versions.
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all their expenses (predicted M=26.1) was similar to the published norm (M=27.0, SD=5.8;
[31]).4 Yet, the HRQOL of survivors with residual expenses not covered by insurance
(predicted M=20.1) was more than one SD below the published norm.
Discussion
Many HSCT survivors report having to cope with persistent stress associated with finances,
employment, and health insurance. Indeed, compared to other cancer populations, they may
be particularly vulnerable to these difficulties because of the expensive and prolonged nature
of HSCT treatment and recovery. As hypothesized and consistent with research on chronic
stress [8–9], these economic survivorship stressors were associated with survivors' physical
and psychological well-being. Specifically, greater perceptions of financial stress and
employment stress were associated with poorer physical, functional, and transplant-specific
functioning. Greater financial stress was also associated with poorer emotional functioning.
These associations could not be explained by survivors' socioeconomic position, background
characteristics, or medical factors. Consistent with stress and coping theory [22], and
relative deprivation theory [23–24], survivors' perceptions of their economic situation were
uniquely associated with their HRQOL. Results suggest that rather than merely being
practical problems complicating survivors' lives, financial and employment difficulties need
to be viewed as sources of chronic stress with implications for survivors' health long after
treatment has ended.
Contrary to our expectations, economic survivorship stress was not associated with social
functioning. Financial limitations can strain interpersonal relationships among cancer
survivors [15], yet these effects may be mitigated by factors such as social support and
coping behaviors [e.g., 43]. It is unknown whether such factors may explain why survivors'
economic problems were unrelated to their social well-being. Furthermore, insurance stress
was not associated with survivors' HRQOL. Although insurance-related problems may be
frustrating without contributing to poor functioning, it is also possible that characteristics of
the sample and study measures made detecting such effects unlikely. Virtually all
participants had health insurance coverage, and the majority of participants' insurance plans
covered all their transplant expenses. This rate of insurance coverage is somewhat higher
than that reported in a recent study in which 6% of non-Hispanic White HSCT patients and
24% of Hispanic HSCT patients were uninsured [44]. Also, our measure of insurance stress
demonstrated relatively little variability (understandable given the favorable insurance status
of most participants) and focused primarily on difficulties encountered during
transplantation rather than on current challenges. Thus, we may have failed to capture
sources of insurance stress in later stages of recovery. As such, further research is warranted.
Results regarding social and situational moderators of associations between economic
survivorship stress and HRQOL further demonstrate the importance of survivors' perceptual
experience of stressors, and although these findings are only marginally statistically
significant after correcting for multiple comparisons, the same pattern of results emerges
across various HRQOL domains and are consistent with existing theory [22–25]. As
predicted, the timing of the financial crisis influenced the strength of the association
between economic survivorship stress and well-being. Whereas survivors assessed before
the crisis experienced steep reductions in HRQOL with increasing stress, survivors assessed
after the crisis experienced only minimal reductions. Furthermore, at the highest levels of
economic survivorship stress, HRQOL among survivors assessed before the crisis was far
4Because published norms for survivors 1-year post-transplant were computed in a manner inconsistent with current scoring
recommendations [42], this comparison used appropriately-computed published norms for survivors 100-days post-transplant.
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poorer than both published norms [41] and that observed among survivors assessed after the
crisis.
These results suggest that the association between economic survivorship stress and
HRQOL was stronger before the economic recession than after. Although it is seemingly
paradoxical that economic survivorship stress is less strongly associated with HRQOL in the
context of the financial crisis, these results are consistent with relative deprivation theory
[23–24], which predicts that disparities in wealth are associated with poorer health in part
because people experience distress upon perceiving their economic standing as worse than
others. It could be that survivors assessed prior to the financial crisis perceived greater
financial inequalities, which led to negative feelings and self-evaluations. However,
survivors assessed after the crisis may have benefited from a perceived reduction in an
inequitable distribution of resources. Such possibilities should be explored with future
studies.
Situational factors also influenced the association between financial stress and transplant-
specific functioning. Among survivors whose health insurance paid for all transplant
expenses, increases in financial stress were associated with minimal decreases in transplant-
specific functioning. Yet, for survivors with residual expenses not covered by insurance,
increasing financial stress was associated with substantial decreases in HRQOL. These
results suggest that survivors with insufficient health insurance coverage may be especially
vulnerable to the detrimental effects of economic survivorship stress.
Limitations and Future Directions
Because this study was cross-sectional, we cannot make firm conclusions about a causal
relationship between economic survivorship stress and health. Associations may be
bidirectional or operate in the reverse direction. For example, survivors in worse health with
poorer functioning are likely to incur greater expenses. We controlled several important
medical variables to address this possibility; these factors did not explain the observed
associations. We relied on novel measures of employment and insurance stress to capture
experiences common to the study population. Although items were developed based on
feedback from HSCT survivors and item wording was modeled after existing measures of
life stressors, it is unclear whether the use of unvalidated measures contributed to the
observed pattern of results. Furthermore, although the occurrence of the financial crisis
during this study provided us with a valuable research opportunity, it should be noted that
the dichotomization of the timing of the financial crisis as pre- and post-September 2008
resulted in subsamples of differing sizes which limited our statistical power for analyses
involving this variable, and may not have fully captured the complex impact of the
economic recession.
The generalizability of these findings is likely limited by the fact that study eligibility
required participants to be moderately distressed and willing to participate in a psychosocial
intervention; this sample reported low levels of financial, employment, and insurance stress;
participants were primarily White/non-Hispanic; many had high incomes (e.g., only 29.2%
reported an income below the 2009 US median household income;[45]); and nearly all were
insured. Yet, despite this sample's objective economic stability, participants' financial stress
scores spanned the full range of the scale and significant associations were consistently
observed across HRQOL domains. To further our understanding of the relationship between
economic survivorship stress and HRQOL, future studies should include a more diverse
group of participants, including those of various racial and ethnic backgrounds,
socioeconomic positions, and insurance statuses. For example, by incorporating measures of
perceived economic survivorship stressors and HRQOL into prospective cohort study
designs that recruit participants at the time of cancer diagnosis, it would be possible to
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determine how these variables are associated among diverse participants, including those
who ultimately fail to proceed to transplant due to financial limitations or those whose
disease recurs. Such studies, using longitudinal designs with multiple assessments across the
treatment and recovery periods, would enhance our knowledge of this important
relationship.
Conclusions
Cancer patients experience multiple challenges during the course of their disease, and for
many, these difficulties persist as they navigate life as a survivor. Given both the steady
increase over the past 40 years in the number of cancer survivors [46], and recent estimates
that over 2 million survivors have forgone one or more needed medical services due to
financial concerns [47], economic challenges represent an emerging area of importance. Our
findings suggest that persistent financial demands and employment complications may be
especially problematic for HSCT survivors' physical and psychological well-being. Yet
these stressors are modifiable determinants of health, particularly to the extent that
survivors' subjective perceptions contribute to their adverse effects. Traditional oncology
treatment strategies focus primarily on physical aspects of patient care [48–49], and are not
well-suited to address survivors' subjective experiences and psychosocial needs related to
economic stressors. Although some resources exist to help survivors cope with financial,
employment, and insurance problems, these services are frequently provided by patient
advocacy groups and non-profit organizations [50], and therefore operate outside the formal
healthcare system. HSCT survivors would benefit from clinical management by
multidisciplnary teams that include psychologists, social workers, patient navigators, or
others with expertise to help survivors adjust to the economic challenges engendered by
their treatment and recovery. Identifying resources and skills that help survivors cope with
these demands is an important goal for clinicians and researchers.
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Appendix A Employment Stressors in Hematopoietic Stem Cell
Transplantation (HSCT) Questionnaire
Instructions. Listed below are a number of job-related events that some people have said are
upsetting to them. If you were working at the time of your diagnosis or transplant, please
indicate whether you experienced each event and how upset you were by it.
Were you working at the time of your diagnosis or transplant?
__ No (stop here and skip remaining questions)






If it did happen, how upsetting was it?










1. Fired from your job as a result
of 0 1 2 3 4
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If it did happen, how upsetting was it?











2. Had to take a paid leave of
absence due to your
illness/transplant
0 1 2 3 4
3. Had to take an unpaid leave of
absence due to your
illness/transplant
0 1 2 3 4
4. Had to quit your job or retire as
a
result of your illness/transplant
0 1 2 3 4
5. Experienced a pay cut or loss of
income due to your
illness/transplant
0 1 2 3 4
6. You had to go on disability due
to
your illness/transplant
0 1 2 3 4
7. You were threatened with
losing
your job due to your
illness/transplant
0 1 2 3 4
8. Your partner's work situation
was
hurt by your illness/transplant
0 1 2 3 4
9. Your employer was
unsupportive 0 1 2 3 4
10. Your partner's employer was
unsupportive 0 1 2 3 4
11. You had to go back to work
too
soon after your illness/transplant
0 1 2 3 4
12. You could not go back to
work as
soon as you wanted after your
illness/transplant
0 1 2 3 4
Note. Responses to Part A are first coded such that “No”=0 and “Yes”=1. Next, for each item, responses to Part A and Part
B are multiplied. The resulting products are then summed. Scores range from 0–48 with higher scores indicating greater
perceived employment stress.
Appendix B Insurance Stressors in Hematopoietic Stem Cell
Transplantation (HSCT) Questionnaire
Instructions. Listed below are a number of events related to health insurance that some
people have said are upsetting to them. Please indicate whether you experienced each event
and how upset you were by it
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If it did happen, how upsetting was it?










1. You had to have your transplant
at a treatment center that was not
your first choice because of your
health insurance coverage
0 1 2 3 4
2. You had to have your transplant
at a treatment center that was far
from home because of your health
insurance coverage
0 1 2 3 4
3. You lost your health insurance
coverage at some point during
your illness/transplant
0 1 2 3 4
4. You had to change health
insurance carriers because of your
illness/transplant
0 1 2 3 4
5. You spent a lot of time dealing
with your health insurance
company (for instance, to arrange
approvals or sort out coverage
problems)
0 1 2 3 4
6. Someone else had to spend a lot
of time dealing with your health
insurance company (for instance,
to arrange approvals and sort out
coverage problems)
0 1 2 3 4
7. Your health insurance company
denied payment at some point
during your illness/transplant
0 1 2 3 4
8. Problems with your health
insurance company caused some
or all of your treatment to be
delayed
0 1 2 3 4
Note. Responses to Part A are first coded such that “No”=0 and “Yes”=1. Next, for each item, responses to Part A and Part
B are multiplied. The resulting products are then summed. Scores range from 0–32, with higher scores indicating greater
perceived insurance stress.
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Timing of the financial crisis and financial stress interact to predict emotional well-being.
Higher emotional well-being scores indicate better HRQOL.
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Portion of the transplant paid by health insurance and financial stress interact to predict
transplant-specific concerns. Higher transplant-specific concerns scores indicate better
HRQOL.
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Gender (female) 100 55.2
Ethnicity
a
 White/non-Hispanic 158 87.3
 Black/African American 5 2.8
 Spanish/Latino/Hispanic 5 2.8
 Caribbean/West Indian 4 2.2
 Asian/Pacific Islander 1 0.6
 Other 8 4.4
Highest level of education completed
 Less than high school 1 0.6
 High school 16 8.8
 Partial college/trade school 38 21.0
 College degree 59 32.6
 Graduate degree 65 35.9
 Missing 2 1.1
Employed by self or others 79 43.6
Annual household income
 Less than $20,000 21 11.6
 $20,000–$35,000 14 7.7
 $35,000–$50,000 18 9.9
 $50,000–$65,000 12 6.6
 $65,000–$80,000 21 11.6
 $80,000–$95,000 21 11.6
 $95,000–$110,000 13 7.2
 Over $110,000 61 33.7
Transplant type
 Allogeneic 97 53.6
 Autologous 84 46.4
Had health insurance at time of transplant 180 99.4
Type of health insurance
 Fee-for-service (e.g., Blue Cross/Blue Shield) 37 20.4
 Health Maintenance Organization (HMO) or other prepaid plan 41 22.7
 PPO or Point of service 76 42.0
 Medicaid 9 5.0
 Medicare 7 3.9
 Other 7 3.9
 Missing 4 2.2
Portion of transplant paid by health insurance
b
 None 1 0.6
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Characteristic n %
 Less than half 0 0.0
 More than half, but not all 65 36.0
 All 107 59.1
 Missing 8 4.4
Assessment before the financial crisis (September 1, 2008) 27 14.9
a
Due to variable frequencies, for analyses ethnicity was recoded as 0=White/non-Hispanic, 1=non-White.
b
Due to variable frequencies, for analyses portion of transplant paid by health insurance was recoded as 0=insurance paid for less than all of
transplant, 1=insurance paid for all of transplant.
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